Literature DB >> 26187029

Ledipasvir-sofosbuvir for hepatitis C genotype 4 infection.

Michael A Smith1, Rima A Mohammad2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26187029     DOI： 10.1016/S1473-3099(15)00223-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  5 in total

Review 1.  Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective.

Authors:  Marcel Nkuize; Thomas Sersté; Michel Buset; Jean-Pierre Mulkay
Journal:  Ther Clin Risk Manag       Date:  2016-06-03       Impact factor: 2.423

Review 2.  Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations.

Authors:  Martin Lagging; Rune Wejstål; Gunnar Norkrans; Olle Karlström; Soo Aleman; Ola Weiland; Maria Castedal; Filip Josephson
Journal:  Infect Dis (Lond)       Date:  2015-12-01

3.  Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection.

Authors:  Ossama A Ahmed; Hany H Kaisar; Rehab Badawi; Nehad Hawash; Hossam Samir; Sherif St Shabana; Mohamed Hassan A Fouad; Fatma H Rizk; Samy A Khodeir; Sherief Abd-Elsalam
Journal:  Infect Drug Resist       Date:  2018-03-01       Impact factor: 4.003

4.  SASLT guidelines: Update in treatment of Hepatitis C virus infection.

Authors:  Abdullah S Alghamdi; Mohammed Alghamdi; Faisal M Sanai; Hamdan Alghamdi; Faisal Aba-Alkhail; Khalid Alswat; Mohammed Babatin; Adel Alqutub; Ibrahim Altraif; Faleh Alfaleh
Journal:  Saudi J Gastroenterol       Date:  2016-08       Impact factor: 2.485

5.  All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findings.

Authors:  Juan Berenguer; Ángela Gil-Martin; Inmaculada Jarrin; Ana Moreno; Lourdes Dominguez; Marisa Montes; Teresa Aldámiz-Echevarría; María J Téllez; Ignacio Santos; Laura Benitez; José Sanz; Pablo Ryan; Gabriel Gaspar; Beatriz Alvarez; Juan E Losa; Rafael Torres-Perea; Carlos Barros; Juan V San Martin; Sari Arponen; María T de Guzmán; Raquel Monsalvo; Ana Vegas; María T Garcia-Benayas; Regino Serrano; Luis Gotuzzo; María Antonia Menendez; Luis M Belda; Eduardo Malmierca; María J Calvo; Encarnación Cruz-Martos; Juan J González-García
Journal:  Hepatology       Date:  2018-04-27       Impact factor: 17.425
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.